receptor neurons in the mouse hypothalamus are colocalized with the neuropeptide galanin and mediate anorexigenic leptin action.
LEPTIN CONTROLS ENERGY HOMEOSTASIS CENTRALLY via neurons that express the long-form leptin receptor (LepRb). Several LepRb populations have been identified based on their anatomic location, coexpression of neuropeptides, or other marker genes (3, 8, 10, 22, 36, 61) that helped to clarify their commensurate contribution to full leptin function. In fact, most LepRb populations studied showed a significant, but surprisingly mild, contribution to full leptin function. However, the majority of LepRb subpopulations has not been studied in detail, largely because of the lack of specific markers for significant subpopulations of LepRb neurons.
Galanin is known as an orexigenic neuropeptide, and galanin neurons are found throughout the brain, but a particularly dense population exists in the dorsomedial hypothalamus. However, orexigenic galanin action is thought to specifically involve its action in the paraventricular nucleus (PVN), because PVN galanin injections most prominently increase food intake (32) . Galanin has been hypothesized to interact with the leptin signaling system, because genetic deletion of galanin amplifies leptin-induced weight loss (24, 25) . It has been hypothesized that leptin may interact with galanin by modulating its gene expression, although the experimental data is scarce and experiments are difficult to compare due to different experimental approaches, detection methods, and anatomic areas investigated; e.g., some studies show that leptin decreases (55, 56) , increases (7) , or has no effect on (62) galanin gene expression.
Likewise, it is unclear whether leptin directly or indirectly acts on galanin neurons, which is again demonstrated in controversial results showing that LepRb is either rarely (7) or extensively (19, 28) colocalized with galanin in the hypothalamus. Both LepRb-and galanin-expressing neurons cannot be easily visualized immunohistochemically. Galanin is rapidly transported into neuronal processes so that immunohistochemical staining for galanin cannot visualize cell bodies unless animals are treated with colchicine to prevent vesicular galanin transport into processes (50) . LepRb is expressed in low quantities so that available LepRb-specific antibodies are not sensitive enough to detect LepRb cell bodies, but LepRbresponsive neurons can be easily and reliably detected by leptin-induced phosphorylation of STAT3 (14, 14, 46, 64) . However, such signaling pathways are blocked by colchicine treatment so that LepRb and galanin cannot be easily detected together. Thus, we hypothesized that earlier studies may have missed the existence of significant galanin-expressing LepRb neurons, and in this study we aimed to reinvestigate the coexpression of galanin and LepRb and to start to evaluate whether and how galanin may mediate physiological leptin action. To do this, we used mice with transgenic green fluorescent protein (GFP) expression from the galanin promoter to systematically characterize the existence, anatomic location, and chemical nature of such Gal-LepRb neurons.
MATERIALS AND METHODS
Mouse strains. To visualize galanin-expressing neurons, we used male BAC transgenic mice (FVB background) with GFP expression under the control of the galanin promoter [Gal TgGFP and Stock Tg(Gal-EGFP)109Gsat; identification no: 0163420UCD], which were obtained from the Mutant Mouse Regional Resource Center (MMRRC; http://www.mmrrc.org), a National Center for Research Resources/ National Institutes of Health-funded strain repository, and donated to the MMRRC by the National Institute of Neurological Disorders and Stroke-funded GENSAT BAC transgenic project (http://www.gensat. org). Gal TgGFP mice and LepRb GFP mice used in this experiment were bred in house by crossing FVB wild-type mice with hemizygous Gal TgGFP or by crossing double homozygous LepRb GFP mice, respectively. Male LepRb GFP mice on a mixed background were used to visualize LepRb neurons and were derived from the colony of Dr. Martin Myers (University of Michigan, Ann Arbor, MI), which has been described in detail elsewhere (38) . Male C57/B6 mice were obtained from The Jackson Laboratory (Bar Harbor, ME). All animals were group housed on a 12:12-h light-dark cycle with ad libitum access to food and water unless stated otherwise. All animal breeding and experimental procedures were approved by the Institutional Animal Care and Use Committee.
Peripheral leptin treatment. To identify LepRb neurons via leptininduced pSTAT3 induction, we treated Gal TgGFP mice (n ϭ 3) or LepRb GFP mice (n ϭ 2) ip with leptin (5mg/kg body wt) and perfused them 1h later. The leptin dose and incubation time were used based on earlier studies showing that leptin-induced pSTAT3 greatly co-localized with LepRb-GFP expressing neurons (14, 36, 39, 64) . Leptin was obtained from Dr. Parlow (National Hormone and Peptide Program; http://www.humc.edu/hormones). For studies investigating leptin-induced cFos (as a surrogate of neuronal activity) in LepRb neurons, we treated LepRb GFP mice with PBS or leptin (5 mg/kg ip) and perfused them after 3 h (n ϭ 3-4/group). Following the treatments, animals were perfused as described below.
In situ hybridization data. To verify correct transgenic galanin-GFP expression, we compared the distribution of GFP expression with the known distribution of galanin mRNA expression. Galanin in situ hybridization data from the Mouse Allen Brain Atlas (Seattle, WA) were used and were available via http://www.brain-map.org. Reproduction of the in situ hybridization images was with the permission of the Allen Institute for Brain Science.
Chronic cannulations for central injections. For central injections, we chronically implanted single cannulas (Plastics One C353, Roanoke, VA) into the lateral ventricle (Ϫ0.3 mm caudal, 1 mm lateral, and 2.1 mm ventral to Bregma) or into the extended perifornical area (exPFA; Ϫ1.8 mm caudal, Ϫ0.9 mm lateral, and Ϫ4.25 mm ventral to Bregma in Gal TgGFP mice and Ϫ1.1 mm caudal, 0.9 mm lateral, and 4.75 mm ventral to Bregma in C57B6 mice). Cannulation procedures have been described in detail previously (14) . Briefly, Gal TgGFP (n ϭ 2 for colchicine injection into the lateral ventricle and n ϭ 8 for intra exPFA cannulation) or C57/B6 mice (n ϭ 12) were deeply anesthetized with 1-3% isofluorane-oxygen, and the head was mounted on a stereotaxic frame (M1900 Stereotaxic alignment system; Kopf Instruments, Tujunga, CA). An incision was made to expose the skull, and an access hole was drilled to insert the guide cannula, which was secured in place with Loctite 454 (Fisher, Pittsburgh, PA) and dental cement before the wound was closed with wound clips. A dummy cannula was inserted into the guide, and analgesia treatment was performed systemically every 12 h for 2 days with buprenorphine (10 g/kg sc) and once locally to the incision site with bupivacainelidocaine (2.5-12.5 mg/kg). Animals were recovered for 1 wk after surgery before injections were performed.
Colchicine treatment. To allow efficient visualization of neurotensin and cocaine-and amphetamine-regulated transcript (CART) in Gal TgGFP mice (n ϭ 2), we injected a single dose of freshly diluted colchicine (1 l of 10 g/l colchicine in sterile saline; Sigma, St. Louis, MO) into the lateral ventricle. Mice were perfused 24 h later.
Central leptin treatment and measurement of metabolic parameters. Gal TgGFP mice and wild-type C57/B6 mice with unilateral exPFA cannulation were habituated to the oxymax chamber for 3 days. After that, mice were monitored daily for body weight and food intake and continuously for oxygen consumption, carbon dioxide production, and locomotor activity (Comprehensive Laboratory Animal Monitoring System; Columbus Instruments, Columbus, OH). After 3 days of baseline data collection, mice were divided into two groups. One group (n ϭ 3-6) received a single leptin injection (20 ng/100 nl sterile PBS), and the other group (n ϭ 3-6) received 100 nl of PBS; injections were performed at a rate of 10 nl/60 s to give time for volume absorption. Leptin doses were used that we found earlier to be sufficient (20 ng) or insufficient (1 ng) to produce a measureable leptin response after central intracerebroventricular injections (14) . Data collection was continued for 4 days postinjection. Mice were allowed to recover for 1 wk in home cages after the last day of measurements. The experiment was then repeated with a lower leptin dose (1 ng/100 nl), and groups were crossed over so that each mouse received leptin only once during the studies (1 or 20 ng). At the end of the study, animals were perfused and analyzed for correct cannula placement, and two mice were removed from the studies due to cannula misplacement (see arrow in Fig. 11D ).
Perfusion and immunohistochemistry. For perfusions, animals were deeply anesthetized with an overdose of pentobarbital sodium (60 mg/kg) and transcardiac perfusion with ice-cold physiological saline for 30 s and ice-cold 10% neutral buffered formalin (Sigma) for 5 min. Brains were removed, postfixed overnight in fixative, and transferred to 30% sucrose for 48 h before being cryosectioned into four representative series per brain of 30-m sections on a sliding microtome. Sections were stained immunohistochemically as described elsewhere (14, 64) using rabbit anti-phospho(Tyr 705 )STAT3 (1:2,000, no. 9131; Cell Signaling Technology, Danvers, MA), rabbit anti-cFos (1:10,000, no. PC38; Millipore, Billerica, MA), rabbit anti-CART (1:3,000, no. H-003-62; Phoenix Pharmaceuticals, Burlingame, CA), rabbit anti-melanin-concentrating hormone (MCH; 1:1,000, no. H-070-47; Phoenix Pharmaceuticals), rabbit anti-orexin (1:1,000, no. AB3704; Millipore), rabbit anti-neurotensin (1:1,000, no. 20072; ImmunoStar, Hudson, WI), rabbit anti-galanin (1:3,000, no. T-4330; Bachem Peninsula, Torrens, CA), rabbit anti-tyrosine hydroxylase (TH; 1:1,000, no. AB152; Millipore), and chicken-anti-GFP (1:1,000, no. ab13970; Abcam, Cambridge, MA) as primary antibodies. Nuclear peptides (c-Fos or p-STAT3) were stained first and developed with the diaminobenzidine method. Staining with additional primary antibodies was performed (neuropeptides and GFP) and detected with fluorescent-labeled secondary antibodies, Alexa 568 (neuropeptides), or Alexa 488 (GFP).
Antibody characterization. The anti-p-STAT3 antibody stains a single band of 80-kDa molecular weight on Western blots after stimulation with ciliary neurotrophic factor (manufacturer's technical information). The specific detection of leptin-induced p-STAT3 was originally characterized by comparison of p-STAT3 signal in vehicle vs. leptin-stimulated brain sections by Western blots and immunohistochemistry (IHC) (14, 46, 47) ; in both cases, leptin robustly increased p-STAT3 signals. Furthermore, induction of p-STAT3 by leptin was found in an anatomic distribution similar to in situ hybridization signals for LepRb (14, 46, 47) , and conditional deletion of LepRb in steroidogenic factor 1 (SF1) or proopiomelanocortin (POMC) neurons resulted in SF1-and POMC-specific lack of leptin-induced p-STAT3, respectively (10, 53) . Specificity of anti-CART and anti-galanin has been tested by omitting the primary antibody and preadsorbing the antibody with the immunogen, which resulted in all cases in a complete lack of staining for all sections (12, 58) . Specificity of anti-MCH, -orexin, -neurotensin, and -TH was verified by analysis of their typical distribution pattern, as reported by others (1, 2, 59). Anti-GFP antibodies were verified by immunohistochemical staining of brains from LepRb GFP reporter mice compared with control mice that do not express GFP (unpublished data) and by colocalization of LepRb GFP with leptin-induced p-STAT3 ( 
and D). E: double immunohistochemistry in Gal
TgGFP mice for galanin-GFP (green) and thyrosine hydroxylase (TH; red), a marker for adrenergic neurons, confirms the adrenergic character of galanin-GFP neurons in the LC. Note that galanin-GFP also visualizes neuronal projections of galanin neurons, which are nicely visible in the precoeruleus that are void of galanin cell bodies. 3V, 3rd ventricle; 4V, 4th ventricle; fx, fornix; ARC, arcuate nucleus; VMH, ventromedial hypothalamus; mt, mamillothalamic tract; preLC, prelocus coeruleus. antibody with the immunogen, which resulted in all cases in a complete lack of staining in all sections (13) .
Leptin-induced gene expression. For assessment of leptin-regulated gene expression in the exPFA, ob/ob mice (8 -10 wk old) were treated twice daily with leptin (5 mg/kg body wt ip) or PBS over 3 days (n ϭ 6/group). On the 3rd day the last injection was given in the morning, and tissue was collected 2 h later. Animals were anesthetized with pentobarbital sodium (60 mg/kg) and decapitated for rapid brain removal. Brains were sliced into 1-mm coronal sections, and the exPFA and arcuate nucleus (ARC) were harvested from a 1-mm coronal brain slice (approximately Ϫ1 to Ϫ2 mm caudal from Bregma). To obtain consistent tissue pieces, we used the mammillothalamic tracts (mt) as landmarks to cut horizontal to the third ventricle (defining the dorsal border of the exPFA). Another cut was made through the mt parallel to the third ventrical (defining the lateral border of the expFA), and a third cut was made laterally to remove any remaining cortex/amygdala structures. No ventral cut was performed, maintaining the natural ventral base of the exPFA. The ARC piece was collected from the ventral portion of the remaining midline piece. RNA was isolated with the ToTALLY RNA kit (Ambion, Carlsbad, CA), and 350 ng RNA was used as a template for the generation of cDNA (RETROscript kit; Ambion, Carlsbad, CA). For quantitative PCR, 10.5 ng of template cDNA was used to determine gene expression using, Taqman assays for suppressor of cytokine signaling-3 (SOCS3; Mm00545913_s1), galanin (Mm01236508_m1), and GapDH (Mm99999915_g1), with the latter serving as a housekeeping gene. Fold induction of gene expression with leptin was analyzed with the ⌬⌬C T method, as recommended for Taqman assays.
Estimates of cell count. We counted the number of LepRb neurons that were colocalized with c-Fos (as a surrogate for stimulated neurons) after PBS or leptin treatment to evaluate whether leptin would stimulate or inhibit exPFA LepRb neurons. Immunohistochemical staining for c-Fos and GFP (LepRb GFP ) was visualized with a fluorescent microscope (Olympus BX51), and images were taken with a digital camera (Olympus DP30BW), using appropriate filters for fluorophores or bright-field illumination for diaminobenzidine stain. Images for c-Fos and GFP were taken at identical sites, superimposed, and pseudocolored using Olympus Software and Adobe Photoshop (Adobe Systems, San Jose, CA). Brightness and contrast were modified for all images to enhance visibility of nuclear p-STAT3 and c-Fos staining for figure preparation and cell counts; however, care was taken so that all images within an experiment were modified with identical settings. For each brain (n ϭ 3-4/group), images from four anatomic levels were taken, representing the rostrocaudal extension of the exPFA (from Bregma Ϫ1.8 to Ϫ2.1 mm, as seen in Fig. 5 ). Because the exPFA consists of three anatomically different locations [including the dorsomedial hypothalamus (DMH), perifornical area, and lateral hypothalamus] that may respond differently to stimuli, we subdivided the exPFA into three subareas for analysis: lateral hypothalamus (LH), perifornical area (PFA), and the DMH. The LH and PFA were separated by a vertical line through the fornix; the DMH and PFA were separated by a vertical line based on the distribution of DMH LepRb neurons. The total number of LepRb GFP neurons and c-Fos/GFP neurons were estimated by cell counts from digital images. The total number of GFP neurons within anatomic sites was analyzed to ensure comparison of similar GFP populations among animals. The number of c-Fos/GFP neurons was expressed as percentage of the total number of GFP neurons in the quantified area. The described cell counts are not intended to provide precise numbers of stimulated GFP neurons. They instead served as estimates for a mainly stimulatory or inhibitory action of leptin in LepRb neurons.
To evaluate the number and percentage of galanin-GFP/p-STAT3 neurons in the exPFA compared with the total number of galanin or p-STAT3 neurons as well as identify coexpression of CART with galanin-GFP/p-STAT3 neurons, we counted cells from Gal TgGFP mice (n ϭ 3) that were treated 1h with leptin, and every fourth section was stained for p-STAT3, GFP, and CART. For each brain, four sections containing the exPFA were used to determine the number of total p-STAT3, total galanin-GFP, galanin-GFP/p-STAT3 double-labeled neurons, and galanin-GFP/p-STAT3/CART triple-labeled neurons within the exPFA. The total number as well as percentage of galanin-GFP/p-STAT3 neurons based on total p-STAT3 or total galanin-GFP neurons was expressed. For CART colocalizatons, the mean number of p-STAT3/GFP/CART neurons was expressed as a percentage of total p-STAT3/GFP neurons in the exPFA.
We further evaluated the extent of colocalization for galanin and neurotensin neurons in colchicine-treated Gal TgGFP mice (n ϭ 2). Although extensive colocalization was easily visible, we performed cell count estimates from four exPFA sections of a single brain. The number of total nucleus of the solitary tract (NTS) neurons and NTS/GFP neurons in the exPFA were determined, and NTS/GFP neurons were expressed as the percentage of total exPFA NTS neurons.
For orexin and MCH colocalization, we evaluated the colocalization of p-STAT3/galanin-GFP with orexin and MCH from Gal TgGFP mouse brains (n ϭ 3). Because we did not observe any colocalization of p-STAT3 or galanin-GFP with orexin or MCH, we did not perform cell counts, and instead we report the anatomic evidence for the lack of colocalization with images.
Statistical analysis. Data were analyzed by Student's t-test (2-group comparison). For physiological data (Fig. 11) , collected repeatedly over several days, we compared groups by one-way repeatedmeasures ANOVA followed by a Holm-Sidak test for pairwise comparisons. The statistical tests used are specified accordingly in the figure legends, and a significance level of P Ͻ 0.05 was used in all tests.
RESULTS

Verification of Gal
TgGFP mice. To verify correct anatomic expression of galanin-GFP in Gal TgGFP mice, we compared GFP expression to in situ hybridization of galanin mRNA expression in adult mice (in situ data kindly provided by the Allen Brain Institute, Fig. 1, A-D) . Indeed, galanin-mRNA expression patterns throughout the brain are very similar, and this is illustrated in detail for the hypothalamus (Fig. 1, A and B) and locus coeruleus (Fig. 1, C and D) .
It is well known that adrenergic neurons in the locus coeruleus are highly coexpressed with galanin (27, 42, 43, 49) . Thus, we further verified correct expression of galanin-GFP by demonstrating their colocalization with TH, a marker for adrenergic neurons, in the locus coeruleus (Fig. 1E) and found every galanin-GFP neuron colocalized with TH.
There are no known markers for galanin-expressing neurons in the exPFA. Thus instead, we stained brain sections from Gal TgGFP mice with anti-galanin to detect galanin peptide as well as with anti-GFP to detect galanin-GFP expression (Fig. 2) . The overall expression pattern of galanin and galanin-GFP fibers was identical, but cell bodies could be detected only with galanin-GFP (Fig. 2, A-C) . Furthermore, confocal high-mag- nification images convincingly showed that galanin-positive fibers highly colocalized with galanin-GFP (Fig. 2, D-F) in the PFA. These data indicate that galanin-GFP expression correctly corresponds with galanin neuropeptide expression, thus verifying Gal TgGFP mice as a useful tool to study galanin expressing neurons.
Distribution of galanin-expressing LepRb neurons. The immunohistochemical detection of LepRb is difficult due to unspecific antibodies or lack of sensitivity. Leptin activates LepRb via the Janus kinase 2/p-STAT3 signaling pathway, resulting in a robust induction of nuclear p-STAT3 that can be detected by Western blotting as well as immunohistochemistry (14, 46, 47) . We used LepRb
GFP reporter mice to demonstrate that LepRb neurons show no p-STAT3 signal when injected with PBS (Fig. 3A) , whereas an intraperitoneal (ip) injection with 5 mg/kg leptin for 1 h resulted in a robust induction of nuclear p-STAT3 that colocalized highly with LepRb GFP neurons (Fig. 3B) . We further confirmed earlier findings that leptin-induced p-STAT3 colocalizes with ϳ80% of LepRb GFP neurons ( Fig. 3C) (36, 64) , demonstrating that leptin-induced p-STAT3 is highly representative for LepRb neurons.
Galanin-GFP neurons are densely packed in the DMH; however, surprisingly, only a small subpopulation in the ventral portion of the DMH (vDMH; Fig. 4A ) coexpressed leptin-induced p-STAT3, marking LepRb-expressing neurons (galanin-GFP/p-STAT3 neurons). The majority of galanin-GFP/p-STAT3 neurons were located in the PFA and lateral hypothalamus, where ϳ20 to 44%, respectively, of all p-STAT3 neurons are colocalized with galanin-GFP (Fig. 4A, 5A , and 6), and 17 to 28%, respectively, of all galanin-GFP neurons were colocalized with p-STAT3 ( Fig. 4A  and 6 ). Another significant population of galanin-GFP/p-STAT3 neurons was found in the nucleus of the solitary tract; here, ϳ25% of all p-STAT3 neurons coexpressed galanin ( Fig. 4B and 5B).
We also carefully examined galanin-GFP neurons in the arcuate nucleus for potential colocalization with leptin-induced p-STAT3. Although we found an occasional colocalization of galanin and p-STAT3, this was negligible compared with the large number of LepRb neurons found in the ARC (Fig. 4C) . In  Fig. 5 , the rostrocaudal distribution of galanin-GFP/p-STAT3 neurons in the hypothalamus (Fig. 5A) and brainstem (Fig. 5B) are shown.
Neuropeptidergic characterization of galanin-GFP/p-STAT3 neurons. Within the lateral hypothalamus, orexin and MCHexpressing neurons are two well characterized neuronal populations that are both known to regulate energy homeostasis. However, neither galanin-nor LepRb-expressing neurons were coloclized with orexin (Fig. 7A) or MCH (Fig. 7B) . Thus, galanin-GFP/p-STAT3 neurons are a distinct population from orexin and MCH neurons.
CART-expressing neurons are well known in the ARC, where they are coexpressed with proopiomelanocortin-expressing neurons and are well known as anorexigenic neurons. Another CART population is found in the lateral hypothalamus, and we found that ϳ56 Ϯ 1.2% (n ϭ 3) of all galanin- Fig. 3 . Leptin-induced p-STAT3 is a marker for long-form leptin receptor (LepRb) neurons. LepRb GFP reporter mice were treated with PBS (A) or leptin (1 mg/kg body wt; B) for 1 h, and perfused brain sections were stained for p-STAT3 (red) and GFP (green). C: cell counts of double-labeled p-STAT3/LepRb GFP neurons in leptin-treated LepRb GFP mice (n ϭ 2) to demonstrate that the majority of leptin-induced p-STAT3 correlates highly with LepRb GFP expression. IHC, immunohistochemistry.
GFP/p-STAT3 neurons in the hypothalamus coexpress CART (Fig. 7C and 8A) .
Recently, Leinninger et. al. (36) showed that a large portion of LH LepRb neurons (ϳ60% of all LH LepRb neurons) coexpresses the anorexigenic neuropeptide neurotensin. Therefore, we wanted to investigate whether galanin-GFP/-neurons would also coexpress neurotensin. Indeed, most identified neurotensin neurons were colocalized with galanin (ϳ95 Ϯ 3% of all neurotensin neurons, n ϭ 2; Figs. 7D and 8B). Neurotensin/galanin colocalization was restricted to the PFA and LH, suggesting that the neurotensin-LepRb neurons identified by Leinninger et. al. (36) may indeed represent galanin-GFP/p-STAT3 neurons (galanin/neurotensin-LepRb neurons). However, neurotensin neurons were not found in the DMH, and the few neurotensin neurons in the NTS rarely colocalized with galanin ( Fig. 7E) , suggesting that a subpopulation of galanin-GFP/p-STAT3 neurons is distinct from neurotensin-LepRb neurons.
Also, many galanin neurons in the LH did not colocalize with neurotensin. Because we were not able to study coexpression of galanin, neurotensin, and LepRb neurons together (colchicine treatment distorts cell-signaling events like STAT3 phosphorylation), we cannot entirely rule out that galanin-GFP/neurotensin neurons may specifically not express LepRb.
However, we propose that galanin-GFP/p-STAT3 neurons consist of at least three neuronal populations: Gal/neurotensinLepRb neurons, Gal/CART-LepRb neurons, and other galanin-GFP/p-STAT3 neurons.
It should be noted that, contrary to the ARC, where anorexigenic and orexigenic neurons represent distinct neuronal populations (e.g., anorexigenic POMC/CART and orexigenic NPY/AgRP neurons), the lateral hypothalamus seems to be organized differently, showing orexigenic galanin coexpressed with anorexigenic neurotensin or CART.
Leptin increases exPFA galanin gene expression. We further tested whether leptin may modulate galanin gene expression specifically in the exPFA. We compared the exPFA of chowfed ob/ob mice treated with either PBS or leptin over 3 days and indeed found that leptin treatment caused a moderate but significant increase in gene expression of galanin (P Ͻ 0.005; Fig. 9A ). To confirm correct leptin stimulation, we compared SOCS3 expression in the exPFA and ARC of PBS and leptintreated mice. Indeed, leptin induced SOCS3 in the ARC (P Ͻ 0.01; Fig. 9C ) and exPFA, although in the exPFA data did not reach significance (P ϭ 0.07; Fig. 9B ).
Leptin stimulates exPFA LepRb neurons. Leptin can cause either a stimulation or inhibition of neuronal activity (4, 9, 48), although LepRb neurons in the LH have been associated mainly with stimulatory leptin action (36) . Thus, we wanted to test whether we could recapitulate leptin stimulation of LepRb neurons in all subdivisions of the exPFA, including the DMH, PFA, and LH (P Ͻ 0.03; Fig. 10 ). We injected LepRb GFP reporter mice with PBS or leptin; perfused brains were harvested 3 h later. After IHC staining, the number of LepRb neurons that were coexpressed with c-Fos as a surrogate for neuronal activity was quantified. As expected, we found that leptin stimulates LepRb neurons in all subdivisions of the exPFA (DMH, PFA, and LH). Leptin-stimulated c-Fos was found in ϳ30 -35% of all LepRb neurons (Fig. 10) , thus indicating that leptin may also stimulate neuronal activity in galanin-GFP/p-STAT3 neurons.
The exPFA is sufficient for anorexigenic leptin action. Given the mixed neuropeptide expression of anorexigenic and orexigenic neuropeptides in galanin-GFP/p-STAT3 neurons, combined with a likely neuronal stimulation of galanin-GFP/p-STAT3 neurons, we wanted to confirm that leptin action in the PFA, where the majority of galanin-GFP/p-STAT3 neurons are found, indeed results in anorexia. Thus, we injected low leptin doses (20 and 1 ng) unilaterally into the PFA of Gal TgGFP and C57B6 mice.
We could confirm that PFA leptin is sufficient to mediate several physiological parameters known to be regulated by systemic leptin. PFA leptin decreased body weight and induced anorexia in Gal TgGFP mice (Fig. 11, A-C) and C57B6 mice (data not shown). Both doses, 20 (data not shown) and 1 ng of leptin (Fig. 11, A-C) , were found to be effective in reducing body weight [P Ͻ 0.01 (ANOVA), P Ͻ 0.05 (Holm-Sidak); Fig. 11A ] and 24-h food intake [P Ͻ 0.05 (t-test); Fig. 11B ], as well as respiratory exchange rate [P Ͻ 0.05 (ANOVA), P Ͻ 0.05 (Holm-Sidak); Fig. 11C ], even though 1 ng of leptin was ineffective in C57B6 mice, which was likely due to differences in leptin sensitivity of the background strain (C57B6 vs. Gal TgGFP mice on an FVB background). Cannula placements in C57B6 (blue dots) and Gal TgGFP (red dots) mice are shown schematically in Fig. 11D , and cases of misplaced cannulas (see arrow in Fig. 11D ) were removed from analysis. Figure 11E shows an example of a cannula track in a Gal TgGFP mouse, using galanin IHC as landmark to show correct targeting of the fornix.
Thus, we show that leptin action in the PFA, including galanin-GFP/p-STAT3 neurons, is sufficient to mediate anorexigenic leptin action in wild-type mice.
DISCUSSION
The aim of this study was to reinvestigate the existence and localization of LepRb neurons that coexpress the neuropeptide galanin, which would characterize a new subgroup of LepRb neurons and would enable future molecular genetic studies to identify the importance of such a LepRb subpopulation for physiological leptin action.
Here, we show convincing evidence that galanin-GFP/ pSTAT3 neurons are found in two distinct brain locations, one in the hypothalamus and another in the brainstem. Leptininduced p-STAT3 is an excellent marker of LepRb-expressing neurons within the exPFA (DMH, PFA, and LH), as shown in Fig. 3 and earlier publications (36, 64) . Thus, in this section we will refer to galanin-GFP/p-STAT3 neurons simply as GalLepRb neurons.
Galanin is well known to induce food intake, and thus not only it is possible that galanin would serve as a genetic marker for a subset of LepRb neurons, but galanin release from Gal-LepRb neurons could also play a role in mediating physiological leptin actions on food intake. Surprisingly, our data support that leptin induces exPFA galanin expression and stimulates neuronal activity in exPFA LepRb neurons, conflicting with an orexigenic action of galanin in this neuronal population. We found that Gal-LepRb neurons further colocalize with anorexigenic neuropeptides like neurotensin or CART and that intra-exPFA leptin clearly mediated anorexia and weight loss.
Technical considerations. We demonstrate that LepRb neurons coexpress the neuropeptide galanin in two distinct populations found within the hypothalamus and brainstem. Similar to an earlier double-in situ hybridization study that focused on coexpression within the ARC and DMH, we found no or only sporadic colocalization in the arcuate nucleus and only a low percentage of colocalization in the DMH (7). But our data contradict previous reports that showed extensive colocalization (60% of all hypothalamic LepRb neurons) in the mouse or ewe. We hypothesized that these discrepancies are due to different methods used that may have lacked specificity (LepRb IHC). This is also supported by the fact that extensive colocalization of LepRb with MCH and orexin was reported (19, 28) . In contrast, our data (using leptin-induced p-STAT3) did not support any colocalization of LepRb with MCH or orexin, which is consistent with earlier published data (36) . Thus, our data show convincingly that leptin can directly act on galanin neurons in the exPFA and the nucleus of the solitary tract in the brainstem. Furthermore, we identified that LepRb and galanin neurons are distinct from orexin and MCH neurons.
LepRb neurons in the brainstem and lateral hypothalamus. LepRb neurons in both the brainstem and LH contribute to the regulation of energy homeostasis (22, 36) . However, the neuropeptides involved in these leptin actions have not been characterized completely. Within the LH, a subpopulation of LepRb neurons coexpresses neurotensin (37) . Our data show that exPFA neurotensin neurons almost entirely coexpressed galanin, although compared with the total number of galanin neurons, neurotensin was found in only a small subset of galanin neurons. Thus, we conclude that the recently described population of neurotensin-LepRb neurons likely coexpresses galanin, although technical limitations prevented us from specifically studying whether Gal-LepRb neurons coexpress neurotensin. Importantly, a subset of Gal-LepRb neurons (at least in the DMH and NTS) clearly does not coexpress neurotensin.
Instead, we found that one-half of all exPFA Gal-LepRb neurons coexpressed the neuropeptide CART, suggesting a heterogeneous character of Gal-LepRb neurons. Surprisingly, we found combined expression of typical anorexigenic (neurotensin, CART) and orexigenic (galanin) neuropeptides, thus conflicting with the classic model of orexigenic or anorexigenic neurons (57) .
Within the exPFA, only LH LepRb neurons have been studied in more detail (36, 37, 40) , characterized as the population distal-lateral to the fornix (20, 36) , thus excluding neurons in the PFA (surrounding the fornix) and DMH (proximal-lateral to the fornix). LH LepRb neurons are sufficient to regulate body weight and food intake in leptin-deficient ob/ob mice. Here, we show that exPFA leptin administration is sufficient to decrease body weight and food intake even in wild-type mice. Neither PFA nor DMH LepRb neurons have been studied in detail for their contribution to regulate energy homeostasis. Certainly, it will be necessary to further investigate the physiological importance of these specific Gal-LepRb populations for known leptin actions such as food intake, energy expenditure, and the rewarding value of food.
Anorexic leptin action via inhibitory galanin action? To understand how leptin may regulate body weight and food intake in the exPFA, we tested whether leptin would regulate the coexpressed neuropeptides. Galanin generally increases food intake (32) , suggesting that anorexigenic leptin action should inhibit galanin expression or block galanin release. Surprisingly, we found that leptin upregulated galanin gene expression moderately, but significantly, in ob/ob mice. Furthermore, leptin stimulates neuronal activity in exPFA LepRb neurons, suggesting that leptin induces galanin release. It is not plausible that anorexigenic leptin action requires increased expression and synaptic release of an orexigenic neuropeptide. Similarly, galanin neurons coexpressed the anorexigenic neuropeptides neurotensin and CART, again conflicting with an orexigenic galanin action. Galanin affects many biological systems from induction of food intake, reproduction to pain, and addiction (18, 26, 45, 52) . Another prominent feature of galanin is its inhibitory action (11, 54, 63) . Interestingly, LH LepRb neurons are generally GABAergic (36), thus further supporting the known inhibitory leptin action on orexin neurons (40) . Indeed, LH galanin injections had no orexigenic effects in rats (32) . Thus, it is plausible to speculate that galanin acts as an inhibitory (instead of orexigenic) neuropeptide in Gal-LepRb neurons and that inhibitory galanin action plays an important role in mediating anorexigenic leptin action via the exPFA. Consistent with this, orexigenic galanin action has been attributed to galanin action with the PVN (32, 44, 60) , whereas LH LepRb neurons do not project to the PVN but rather locally in the LH and to the ventral tegmental area (36) .
Leptin regulation of exPFA galanin gene expression. A correlation of leptin and galanin gene expression has been studied by others, with very inconsistent results showing that leptin decreased galanin in the hypothalamus of wild-type mice (55, 56) , had no effect on galanin expression, comparing leptin-deficient ob/ob and wild-type mice (62), or increased galanin expression specifically in the periventricular region of leptin-treated ob/ob mice (7). The results presented here would support leptin-induced gene expression in the exPFA, although this was not a robust effect. exPFA galanin neurons may represent a heterogenous neuronal population of neurons that are coexpressed with several neuropeptides with or without LepRb. Thus, leptin may regulate galanin expression differentially in subpopulations of galanin neurons. Furthermore, it needs to be cautioned that mRNA expression may not reflect the quantity of functional galanin at the synapses or the amount of galanin that is indeed released into the synaptic cleft.
Therefore, changes in mRNA galanin expression may simply not correlate with changes in behavior.
Leptin robustly stimulates c-Fos, a marker of neuronal activity, in exPFA LepRb neurons, suggesting increased neuropeptide release such as galanin. However, we could not determine whether leptin-induced LepRb neurons indeed included Gal-LepRb neurons, and we cannot rule out that leptin may exclusively stimulate nongalanin LepRb neurons in the exPFA. Indeed, in the LH as well as other hypothalamic sites, leptin exerts depolarizing and hyperpolarizing effects on individual LepRb populations (9, 36) . Future studies are necessary to test whether galanin indeed contributes to inhibitory leptin actions [e.g., inhibition of orexin neurons (40) ] and to demonstrate how this affects anorexigenic leptin action.
The PFA and LH are generally involved in reward behavior (5) and regulate sleep and arousal via orexin neurons. Similarly, leptin (15, 16, 34 -36, 41) , galanin (21, 52) , neurotensin (6, 17, 23, 30) , and CART (29, 31, 51) have all been associated with the control of reward as well as arousal behavior. Indeed, neurotensin-LepRb neurons modulate the reward system via orexin neurons, although it is still unknown by which mechanisms leptin inhibits orexin neurons (40) . The fact that subpopulations of exPFA Gal-LepRb neurons also coexpress neurotensin or CART suggests that Gal-LepRb neurons may be involved in the regulation of reward and arousal possibly via orexin neurons that could be inhibited by leptin-induced galanin release.
In summary, we present clear evidence that LepRb is expressed on galanin neurons in two distinct locations, one in the hypothalamus and another in the brainstem. Surprisingly, several Gal-LepRb neurons further colocalized with the anorexigenic neuropeptides neurotensin or CART. However, intraexPFA leptin action clearly demonstrated that leptin mediates anorexia and body weight loss in the exPFA. Furthermore, leptin induced galanin gene expression in the exPFA of ob/ob mice and neuronal activity in exPFA LepRb neurons, thus conflicting with an orexigenic galanin action in this system. Galanin has also been well known as an inhibitory-acting neuropeptide (11, 54, 63) , and thus we speculate that galanin may act alternatively as an inhibitory neuropeptide rather than an orexigenic neuropeptide in Gal-LepRb neurons.
